Author

Jonathan Bordat

Institutions: Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis

Observed institutions: Centre Hospitalier Universitaire Henri-Mondor, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Henri-Mondor, Hôpital Saint-Louis

OpenAlex ID: A5066872278

Allogeneic hematopoietic stem cell transplantation in the COVID-19 era

2023 · Jonathan Bordat, Sébastien Maury, et al. · Frontiers in Immunology · 12

Post-transplant cyclophosphamide improves survival compared to antithymocyte globulin in HLA-mismatched unrelated donor stem cell transplantation

2025 · Jonathan Bordat, Eleonore Kaphan, et al. · Haematologica · 2

Low-dose non-steroidal anti-inflammatory drugs: a promising approach for the treatment of symptomatic bone marrow failure in Ghosal hematodiaphyseal dysplasia

2024 · Jonathan Bordat, Felipe Suarez, et al. · Haematologica · 1

GvHD prophylaxis in elderly patients: post-transplant cyclophosphamide or ATG? A study by the EBMT transplant complications working party

2026 · Lars Klingen Gjærde, Christophe Peczynski, et al. · Bone Marrow Transplantation

Ptcy Versus High Dose of ATG in HLA-Mismatched Unrelated Stem Cell Transplantation for Hematological Malignancies

2024 · Jonathan Bordat, Eléonore Kaphan, et al. · Blood

Works count: 5

Citation count: 15

H-index: 2

I10-index: 1